Ilera Health Enhances Its Team
Pennsylvania’s premiere medical cannabis cultivation and dispensary company, IleraHealthcare, has tapped Dr. Oludare “Dare” Odumosu as Chief Scientific Officer/EVP Pharmaceutical Division. Dr. Odumosu will be charged with driving research, development and implementation of Ilera’s proprietary ‘pharmaceutical-grade’ medicines and therapeutic platforms to the global marketplace.
Dr. Odumosu, who holds a PhD in Biochemistry and a Master’s in Public Health-Epidemiology and Biostatistics, brings 10 years of experience in corporate pharmaceutical business development, operations and strategic alliance management to his new role.
In addition, Tom Borger will be joining the Ilera Healthcare team as their new Chief Operating Officer with a focus on building a world class marketing and retail operation. Borger brings a unique blend of marketing, technology and general management experience and has worked extensively in both start-up and large companies—including Johnson & Johnson and GlaxoSmithKline. He is a Duke graduate who earned his MBA in Entrepreneurial Management/Marketing from the Wharton School of Business, and has taught courses at Wharton’s Small Business Development Center and Villanova’s School of Business. He is the author of an innovation book, Diary of an Innovator—Finding the Path Not Taken and delivered a TEDx talk—“The Power of Inexperience.”
23 chronic insomnia patients treated with ZLT-101, Zelira’s proprietary and patented medicinal cannabis formulation, demonstrated statistically significant improvement in Insomnia Severity Index scores compared to placebo.
This research evaluates thousands of subjects who are current or past participants in the Pennsylvania Medical Marijuana Program who were asked to answer a variety of questions based on their first-hand experience.
As more of our patients are consuming cannabis on a regular basis, a common issue seems to be arising – TOLERENCE.